We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+7.75%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$7.54B
AUM Growth
+$509M
Cap. Flow
+$81.8M
Cap. Flow %
1.08%
Top 10 Hldgs %
15.04%
Holding
1,277
New
87
Increased
539
Reduced
599
Closed
49

Sector Composition

Rank Sector Weight
1 Technology 21.29%
2 Healthcare 13.85%
3 Financials 13.17%
4 Consumer Discretionary 10.27%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRLN icon
151
State Street Blackstone Senior Loan ETF
SRLN
$5.34B
$12.2M 0.16%
268,105
-305
-0.1% -$13.9K
AMED
152
DELISTED
Amedisys
AMED
$12.2M 0.16%
75,569
+24,038
+47% +$3.86M
CNC icon
153
Centene
CNC
$32.5B
$12.2M 0.16%
148,058
+5,457
+4% +$400K
PSX icon
154
Phillips 66
PSX
$81.4B
$12.1M 0.16%
166,811
-5,996
-3% -$453K
KMB icon
155
Kimberly-Clark
KMB
$36.5B
$12.1M 0.16%
84,550
+188
+0.2% +$25.3K
INTU icon
156
Intuit
INTU
$89B
$12M 0.16%
18,612
-1,423
-7% -$878K
VICI icon
157
VICI Properties
VICI
$29.4B
$12M 0.16%
397,381
-36,686
-8% -$1.06M
SRE icon
158
Sempra
SRE
$54.8B
$11.9M 0.16%
179,794
+1,292
+0.7% +$81.9K
COST icon
159
Costco
COST
$420B
$11.8M 0.16%
20,873
-1,548
-7% -$793K
AMAT icon
160
Applied Materials
AMAT
$428B
$11.6M 0.15%
73,922
+790
+1% +$114K
EW icon
161
Edwards Lifesciences
EW
$51.7B
$11.3M 0.15%
87,064
+1,053
+1% +$123K
SNY icon
162
Sanofi
SNY
$104B
$11.1M 0.15%
221,562
-11,910
-5% -$589K
RWO icon
163
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.3B
$11M 0.15%
194,343
+59,768
+44% +$3.25M
XLI icon
164
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
$11M 0.15%
103,775
+9,163
+10% +$952K
AZO icon
165
AutoZone
AZO
$51.1B
$11M 0.15%
5,237
-392
-7% -$730K
CAT icon
166
Caterpillar
CAT
$387B
$11M 0.15%
53,052
+17,144
+48% +$3.45M
IJT icon
167
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.42B
$11M 0.15%
+78,948
New +$10.7M
BIIB icon
168
Biogen
BIIB
$30.7B
$10.9M 0.15%
45,578
-6,960
-13% -$1.79M
FMC icon
169
FMC
FMC
$1.33B
$10.9M 0.14%
98,749
+596
+0.6% +$59.9K
BURL icon
170
Burlington
BURL
$23.2B
$10.8M 0.14%
37,129
+60
+0.2% +$16.9K
SNPS icon
171
Synopsys
SNPS
$79.7B
$10.8M 0.14%
29,226
-1,365
-4% -$460K
WBA
172
DELISTED
Walgreens Boots Alliance
WBA
$10.7M 0.14%
204,436
-1,464
-0.7% -$70.9K
TTE icon
173
TotalEnergies
TTE
$190B
$10.6M 0.14%
213,311
+4,668
+2% +$232K
VTI icon
174
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$10.5M 0.14%
43,563
+41,784
+2,349% +$9.86M
ICE icon
175
Intercontinental Exchange
ICE
$84.4B
$10.5M 0.14%
76,884
+4,467
+6% +$592K

Similar funds

Oppenheimer Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Oppenheimer Asset Management held 1,277 positions worth $7.54B, up 7.2% from $7.03B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer Asset Management's Q4 2021 filing shows 87 new, 539 increased, 599 reduced and 49 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 241,081 shares worth $14.8M. The largest sale was Autodesk, an estimated $9.15M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer Asset Management's largest Q4 2021 buy was Vanguard FTSE All-World ex-US ETF: 241,081 shares worth $14.8M.
  • Oppenheimer Asset Management added most to iShares Currency Hedged MSCI EAFE ETF in Q4 2021, an estimated $18.6M increase.
  • Oppenheimer Asset Management's biggest Q4 2021 reduction was Autodesk, cutting an estimated $9.15M.
  • Oppenheimer Asset Management fully exited iShares MSCI EAFE Growth ETF in Q4 2021, selling an estimated $7.45M.
  • Oppenheimer Asset Management's ten largest holdings make up 15% of its $7.54B portfolio in Q4 2021.
  • Oppenheimer Asset Management opened 87 new positions and closed 49 in Q4 2021.
  • Oppenheimer Asset Management's portfolio value rose 7.2% quarter-over-quarter to $7.54B.

Based on Oppenheimer Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.